Peripheral vascular disease -- also known by the acronym PVD -- is a disease that affects the veins surrounding the heart. With PVD, these veins can become misshapen and spasm, restricting blood flow to the extremities and causing severe pain and fatigue. Peripheral vascular disease treatment can be highly invasive: but platelet replacement therapy and stem cell therapy for peripheral vascular disease are changing the game.
Greyledge supports vein specialists in offering the most cutting-edge cell therapy available to those who are seeking a minimally-invasive alternative to traditional therapies for PVD. Made using technology at the forefront of regenerative tissue therapy, our , , and preparations allow your specialist to tailor your treatment to your individual needs.
Greyledge will enable your vein specialist and primary care provider to offer you custom support for your heart. Ready to take your life back? Talk to your doctor about Greyledge today, or find a Greyledge-partnered physician near you.
Greyledge’s capabilities include creating a number of cutting-edge regenerative preparations for use by vein specialists, including platelet-rich plasma, or PRP. Here’s how the process of creating PRP works:
PRP stimulates your body’s natural ability to heal, allowing for a faster, more effective recovery from PVD and eliminating any related pain in your extremities.
To learn more about how PRP can help you recover more effectively from peripheral vascular disease, reach out to us -- we’re happy to discuss our capabilities with you or your vascular specialist.
Vascular disease and stem cell therapies go hand in hand. Stem cells are unique in the fact that they don’t just serve one predetermined purpose -- they exist at a stage in which they can transform into any other type of cell, allowing them to become whichever cell is necessary to restore the tissues that make up the veins affected by PVD. They can even serve a “leadership role” among your cells, rallying other cells to do the same.
In this way, bone marrow cellular concentrate (BMC) can offer a non-invasive alternative to traditional treatments for peripheral vascular disease. Here’s how we prepare autologous BMC at Greyledge:
The abilities of the stem and progenitor cells found in bone marrow aspirate makes BMCC extremely valuable in allowing your body to reconstruct damaged veins, reducing and eventually eliminating the pain you feel as a result of PVD.
Both PRP and PPP are types of plasma that can be extracted from whole blood samples. The difference is, PRP contains a great deal of platelets, while PPP contains very few. This way, the two can be used to balance one another to create the perfect custom biologics preparation for you.
Prolotherapy involves injecting a sugar-like irritant (dextrose) into an area where a patient is experiencing pain. Like PRP, prolotherapy is known to stimulate healing -- however, unlike PRP, it involves the injection of a completely foreign body into the affected area, as opposed to the patient’s own plasma. Greyledge products contain only autologous (your own) plasma.
Alternatively, you may be able to find a physician who has already partnered with Greyledge and is providing fully-customizable cell therapy near you. If you’d like to get started with one of the most innovative biologics companies in the field, today.